Malignant melanoma: clinical variants and prognostic indicators

Area of Science:

• Dermatology
• Oncology
• Pathology

Background:

• Melanoma classification requires refinement for research accuracy.
• Understanding diverse melanoma subsets is crucial for effective treatment strategies.
• Existing prognostic indicators need further validation and integration.

Purpose of the Study:

• To present and justify the retention of four main clinicopathological melanoma subsets in research.
• To describe additional melanoma subsets, including rare presentations.
• To discuss pathological prognostic indicators and the need for personalized predictive tools.

Main Methods:

• Review of existing literature on melanoma classification and prognostication.
• Analysis of clinicopathological features of different melanoma subsets.
• Discussion of prognostic indicators such as tumor thickness and ulceration.

Main Results:

• The four primary clinicopathological melanoma subsets are detailed with arguments for their research utility.
• Additional subsets like partly regressed melanoma and melanoma in congenital nevi are described.
• Tumor thickness and ulceration are identified as key prognostic indicators.

Conclusions:

• Retention of established melanoma subsets is vital for consistent research.
• Accurate prognostic profiling requires consideration of individual patient data.
• Development of a molecular marker for melanoma metastatic potential is a critical future direction.